Atossa Therapeutics, Inc.
ATOS
$0.6231
$0.01812.99%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 71.08M | 74.77M | 79.53M | 83.96M | 88.46M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | 2.10M | 1.29M | 1.10M | 1.37M | 1.49M |
| Prepaid Expenses | 696.00K | 250.00K | 579.00K | 1.11M | 1.30M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 579.00K | 810.00K | 518.00K | 618.00K | 977.00K |
| Total Current Assets | 74.46M | 77.11M | 81.72M | 87.06M | 92.22M |
|
|
|||||
| Total Current Assets | 74.46M | 77.11M | 81.72M | 87.06M | 92.22M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.99M | 2.37M | 2.43M | 2.32M | 2.32M |
| Total Assets | 76.44M | 79.48M | 85.86M | 91.09M | 96.25M |
|
|
|||||
| Total Accounts Payable | 679.00K | 1.56M | 1.06M | 1.23M | 806.00K |
| Total Accrued Expenses | 2.78M | 2.76M | 2.85M | 2.27M | 2.63M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 1.51M | 1.48M | 1.79M | 1.83M | 1.80M |
| Total Other Current Liabilities | 1.51M | 1.48M | 1.79M | 1.83M | 1.80M |
| Total Current Liabilities | 4.97M | 5.80M | 5.70M | 5.33M | 5.24M |
|
|
|||||
| Total Current Liabilities | 4.97M | 5.80M | 5.70M | 5.33M | 5.24M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 4.97M | 5.80M | 5.70M | 5.33M | 5.24M |
|
|
|||||
| Common Stock & APIC | 284.74M | 280.60M | 279.85M | 279.40M | 278.78M |
| Retained Earnings | -211.79M | -205.45M | -198.22M | -192.17M | -186.29M |
| Treasury Stock & Other | -1.48M | -1.48M | -1.48M | -1.48M | -1.48M |
| Total Common Equity | 71.48M | 73.68M | 80.16M | 85.76M | 91.02M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 71.48M | 73.68M | 80.16M | 85.76M | 91.02M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 71.48M | 73.68M | 80.16M | 85.76M | 91.02M |
|
|
|||||